Literature DB >> 22156573

A persistent stress response to impeded axonal transport leads to accumulation of amyloid-β in the endoplasmic reticulum, and is a probable cause of sporadic Alzheimer's disease.

Virgil Muresan1, Zoia Muresan.   

Abstract

BACKGROUND AND
OBJECTIVE: Could a normal--but persistent--stress response to impeded axonal transport lead to late-onset Alzheimer's disease (AD)? Our results offer an affirmative answer, suggesting a mechanism for the abnormal production of amyloid-β (Aβ), triggered by the slowed axonal transport at old age. We hypothesize that Aβ precursor protein (APP) is a sensor at the endoplasmic reticulum (ER) that detects, and signals to the nucleus, abnormalities in axonal transport. When persistently activated, due to chronically slowed-down transport, this signaling pathway leads to accumulation of Aβ within the ER. METHODS AND
RESULTS: We tested this hypothesis with the neuronal cell line CAD. We show that, normally, a fraction of APP is transported into neurites by recruiting kinesin-1 via the adaptor protein, Fe65. Under conditions that block kinesin-1-dependent transport, APP, Fe65 and kinesin-1 accumulate in the soma, and form a complex at the ER. This complex recruits active c-Jun N-terminal kinase (JNK), which phosphorylates APP at Thr(668). This phosphorylation increases the cleavage of APP by the amyloidogenic pathway, which generates Aβ within the ER lumen, and releases Fe65 into the cytoplasm. Part of the released Fe65 translocates into the nucleus, likely to initiate a gene transcription response to arrested transport. Prolonged arrest of kinesin-1-dependent transport could thus lead to accumulation and oligomerization of Aβ in the ER.
CONCLUSION: These results support a model where the APP:Fe65 complex is a sensor at the ER for detecting the increased level of kinesin-1 caused by halted transport, which signals to the nucleus, while concomitantly generating an oligomerization-prone pool of Aβ in the ER. Our hypothesis could thus explain a pathogenic mechanism in AD.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156573      PMCID: PMC3363352          DOI: 10.1159/000332815

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  18 in total

1.  Intraneuronal Abeta42 accumulation in human brain.

Authors:  G K Gouras; J Tsai; J Naslund; B Vincent; M Edgar; F Checler; J P Greenfield; V Haroutunian; J D Buxbaum; H Xu; P Greengard; N R Relkin
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60.

Authors:  X Cao; T C Südhof
Journal:  Science       Date:  2001-07-06       Impact factor: 47.728

3.  Neuritic deposits of amyloid-beta peptide in a subpopulation of central nervous system-derived neuronal cells.

Authors:  Zoia Muresan; Virgil Muresan
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

4.  The amyloid-beta precursor protein is phosphorylated via distinct pathways during differentiation, mitosis, stress, and degeneration.

Authors:  Zoia Muresan; Virgil Muresan
Journal:  Mol Biol Cell       Date:  2007-07-18       Impact factor: 4.138

5.  Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation.

Authors:  Y Qi; J K Wang; M McMillian; D M Chikaraishi
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

6.  Phosphorylation of a tyrosine in the amyloid-beta protein precursor intracellular domain inhibits Fe65 binding and signaling.

Authors:  Dawang Zhou; Nicola Zambrano; Tommaso Russo; Luciano D'Adamio
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  Structure of the intracellular domain of the amyloid precursor protein in complex with Fe65-PTB2.

Authors:  Jens Radzimanowski; Bernd Simon; Michael Sattler; Konrad Beyreuther; Irmgard Sinning; Klemens Wild
Journal:  EMBO Rep       Date:  2008-10-03       Impact factor: 8.807

8.  Is abnormal axonal transport a cause, a contributing factor or a consequence of the neuronal pathology in Alzheimer's disease?

Authors:  Virgil Muresan; Zoia Muresan
Journal:  Future Neurol       Date:  2009-11-01

Review 9.  Seeding neuritic plaques from the distance: a possible role for brainstem neurons in the development of Alzheimer's disease pathology.

Authors:  Zoia Muresan; Virgil Muresan
Journal:  Neurodegener Dis       Date:  2008-03-06       Impact factor: 2.977

10.  APP processing is regulated by cytoplasmic phosphorylation.

Authors:  Ming-Sum Lee; Shih-Chu Kao; Cynthia A Lemere; Weiming Xia; Huang-Chun Tseng; Ying Zhou; Rachael Neve; Michael K Ahlijanian; Li-Huei Tsai
Journal:  J Cell Biol       Date:  2003-10-13       Impact factor: 10.539

View more
  10 in total

1.  Functional interaction between amyloid-β precursor protein and peripherin neurofilaments: a shared pathway leading to Alzheimer's disease and amyotrophic lateral sclerosis?

Authors:  Virgil Muresan; Christine Villegas; Zoia Ladescu Muresan
Journal:  Neurodegener Dis       Date:  2013-09-04       Impact factor: 2.977

2.  Dual-tagged amyloid-β precursor protein reveals distinct transport pathways of its N- and C-terminal fragments.

Authors:  Christine Villegas; Virgil Muresan; Zoia Ladescu Muresan
Journal:  Hum Mol Genet       Date:  2013-11-07       Impact factor: 6.150

Review 3.  Amyloid-β precursor protein: Multiple fragments, numerous transport routes and mechanisms.

Authors:  Virgil Muresan; Zoia Ladescu Muresan
Journal:  Exp Cell Res       Date:  2015-01-06       Impact factor: 3.905

4.  Transcriptome analysis of distinct mouse strains reveals kinesin light chain-1 splicing as an amyloid-β accumulation modifier.

Authors:  Takashi Morihara; Noriyuki Hayashi; Mikiko Yokokoji; Hiroyasu Akatsu; Michael A Silverman; Nobuyuki Kimura; Masahiro Sato; Yuhki Saito; Toshiharu Suzuki; Kanta Yanagida; Takashi S Kodama; Toshihisa Tanaka; Masayasu Okochi; Shinji Tagami; Hiroaki Kazui; Takashi Kudo; Ryota Hashimoto; Naohiro Itoh; Kouhei Nishitomi; Yumi Yamaguchi-Kabata; Tatsuhiko Tsunoda; Hironori Takamura; Taiichi Katayama; Ryo Kimura; Kouzin Kamino; Yoshio Hashizume; Masatoshi Takeda
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-04       Impact factor: 11.205

5.  Shared Molecular Mechanisms in Alzheimer's Disease and Amyotrophic Lateral Sclerosis: Neurofilament-Dependent Transport of sAPP, FUS, TDP-43 and SOD1, with Endoplasmic Reticulum-Like Tubules.

Authors:  Virgil Muresan; Zoia Ladescu Muresan
Journal:  Neurodegener Dis       Date:  2015-11-26       Impact factor: 2.977

6.  Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers.

Authors:  E Ferreiro; I Baldeiras; I L Ferreira; R O Costa; A C Rego; C F Pereira; C R Oliveira
Journal:  Int J Cell Biol       Date:  2012-06-04

7.  Localization and Processing of the Amyloid-β Protein Precursor in Mitochondria-Associated Membranes.

Authors:  Dolores Del Prete; Jan M Suski; Bénédicte Oulès; Delphine Debayle; Anne Sophie Gay; Sandra Lacas-Gervais; Renaud Bussiere; Charlotte Bauer; Paolo Pinton; Patrizia Paterlini-Bréchot; Mariusz R Wieckowski; Frédéric Checler; Mounia Chami
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membrane.

Authors:  Liang Zhang; Sergey Trushin; Trace A Christensen; Utkarsh Tripathi; Courtney Hong; Rachel E Geroux; Kyle G Howell; Joseph F Poduslo; Eugenia Trushina
Journal:  Neurobiol Dis       Date:  2018-03-02       Impact factor: 5.996

9.  Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer's Disease and Reconstruction of Relevant Biological Mechanisms.

Authors:  Shashank Khanna; Daniel Domingo-Fernández; Anandhi Iyappan; Mohammad Asif Emon; Martin Hofmann-Apitius; Holger Fröhlich
Journal:  Sci Rep       Date:  2018-07-24       Impact factor: 4.379

Review 10.  Modifications and Trafficking of APP in the Pathogenesis of Alzheimer's Disease.

Authors:  Xin Wang; Xuan Zhou; Gongying Li; Yun Zhang; Yili Wu; Weihong Song
Journal:  Front Mol Neurosci       Date:  2017-09-15       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.